The Bulletin


.

Jennewein Biotechnologie GmbH and Chr. Hansen A/S to join forces in high-growth Human Milk Oligosaccharides market-PR Newswire APAC

  • Written by PR Newswire

RHEINBREITBACH and BONN, Germany, Sept. 22, 2020 /PRNewswire/ -- Jennewein Biotechnologie GmbH agreed to join forces with Chr. Hansen Holding A/S, a leading bioscience company based in Hoersholm/Denmark, to lead the global market for human milk oligosaccharides (HMOs). Chr. Hansen entered into an agreement to acquire all shares in Jennewein...